Loading organizations...
Namarel Ventures operates as an early-stage investment firm, strategically focused on identifying and nurturing companies within the dynamic healthcare sector. The firm provides both capital and strategic expertise to nascent businesses developing disruptive technologies, particularly in medical devices, diagnostics, and digital health solutions. Its investment thesis prioritizes supporting innovative health technologies and early-stage entrepreneurs to bring impactful solutions to market.
The venture’s investment activities commenced in 2018, drawing inspiration from the resourcefulness and entrepreneurial spirit observed in a sub-Saharan village. This insight underpins its commitment to fostering innovation. Namarel Ventures is managed by a team with profound experience across the health sector, encompassing the entire lifecycle from startup creation to successful product commercialization, guiding its strategic investment decisions.
Namarel Ventures primarily serves pioneering entrepreneurs and emerging companies actively shaping the future of health technology. Its core mission is to catalyze innovation and effectively address critical challenges that can fundamentally transform the global healthcare market. The company envisions itself as a leading and trusted partner for both the entrepreneurs it supports and its fellow investors within the specialized healthcare investment landscape, fostering long-term impact.
Namarel Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $2.4M Debt / Seed in Health Lean Analytics in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2026 | Health Lean Analytics | $2.4M Debt / Seed | — | Braincats, Enisa, Inderhabs |
| Nov 27, 2023 | MiMARK | $4.6M Seed | — | Canterbury Scientific, Cdti, Clave Capital, EIC Fund, Inveready, Nara Capital, Wa4steam |